Sofie

SOFIE is a leading molecular imaging company specializing in the development and commercialization of radiopharmaceuticals used in positron emission tomography (PET) imaging. They generate revenue through the production and distribution of these imaging agents, as well as providing contract manufacturing services. Founded in 2008, SOFIE has a significant history of innovation in molecular diagnostics and has expanded its footprint through strategic acquisitions and partnerships, enhancing its capabilities in the precision medicine landscape.

Recent Posts by Sofie

1-20 of 80